Ming-Yi Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Ming-Yi Wang has a total of 112 co-authors. Here are the top co-authors by number of shared publications:
Dong Guo
Department of Central Lab, Weihai Municipal Hospital, Cheeloo College of Medicine, Shandong University, Weihai, Shandong, 264200, PR China
6 shared publicationsPeng Liu
Shandong University
6 shared publicationsJing Zhang
Marine College, Shandong University
4 shared publications- Yusen Zhang
School of Mathematics and Statistics, Shandong University, Weihai 264209, China
4 shared publications Hai-Yan Cong
Department of Central Lab, Weihai Municipal Hospital, Cheeloo College of Medicine, Shandong University, Weihai, Shandong 264200, P.R. China
3 shared publications- Hong Luo
College of Medical Laboratory, Dalian Medical University, Dalian, PR China
3 shared publications
Latest Publications
- 22 October 2026
- Published by Elsevier in Environmental Toxicology and Pharmacology
- Vol. 128, 105202
The interplay between microplastics and respiratory viral diseases
- 22 October 2026
- Published by Elsevier in Environmental Toxicology and Pharmacology
- Vol. 128, 105202
The interplay between microplastics and respiratory viral diseases
- 20 January 2026
- Published by Elsevier in Journal of Hazardous Materials
- Vol. 503, 141203
Organophosphate diesters interfere with hypochlorous acid-induced phospholipid reactions at the air-water interface
- 20 January 2026
- Published by Elsevier in Journal of Hazardous Materials
- Vol. 503, 141203
Organophosphate diesters interfere with hypochlorous acid-induced phospholipid reactions at the air-water interface
- Open Access
- 18 July 2025
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 16, 1642517
Six new bacterial species isolated from the phycosphere of marine macroalgae: a joint analysis based on taxonomy and polysaccharide utilization loci
Marine macroalgae-associated Bacteroidota play crucial roles in global carbon cycling through polysaccharide degradation, yet their taxonomic and functional diversity remains understudied. Here, we describe six novel species (strains 3-376 T , 4-2040 T , 2-473A T , 4-528 T , 4-911 T and 463 T ) within the families Flavobacteriaceae , Crocinitomicaceae , and Cytophagaceae isolated from macroalgal surfaces in the coastal area of Weihai, China. Metagenomic read recruitment and 16S rRNA abundance analyses demonstrated host-specific associations. Integrative taxonomic analyses, including phylogenomics (120 conserved proteins), 16S rRNA sequencing, and chemotaxonomy (e.g., MK-6 quinones, phosphatidylethanolamine lipids, and iso-C 15:0 fatty acids), confirmed their novel status, with average amino acid identity (AAI), percentage of conserved proteins (POCP) distinguishing them from related taxa. Genomes (3.3–7.1 Mb; G + C 31.7–45.3%) revealed diverse polysaccharide utilization loci (PULs) targeting algal glycans like laminarin, alginate, and sulfated polymers (ulvan, chondroitin sulfate). Cytophagaceae 463 T harbored the richest CAZyme/PUL repertoire (131 CAZymes, 15 PULs), while Crocinitomicaceae 4-911 T lacked PULs, highlighting family-level specialization. This study expands the known diversity of core phycosphere Bacteroidota , linking PUL evolution to habitat specialization. The novel species’ distinct degradative capacities underscore their ecological roles in algal carbon processing and potential for biotechnological applications. Our integrated taxonomy-genomics approach advances understanding of microbial contributions to marine ecosystem dynamics.
- 18 July 2025
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 16, 1642517
Open AccessSix new bacterial species isolated from the phycosphere of marine macroalgae: a joint analysis based on taxonomy and polysaccharide utilization loci
Marine macroalgae-associated Bacteroidota play crucial roles in global carbon cycling through polysaccharide degradation, yet their taxonomic and functional diversity remains understudied. Here, we describe six novel species (strains 3-376 T , 4-2040 T , 2-473A T , 4-528 T , 4-911 T and 463 T ) within the families Flavobacteriaceae , Crocinitomicaceae , and Cytophagaceae isolated from macroalgal surfaces in the coastal area of Weihai, China. Metagenomic read recruitment and 16S rRNA abundance analyses demonstrated host-specific associations. Integrative taxonomic analyses, including phylogenomics (120 conserved proteins), 16S rRNA sequencing, and chemotaxonomy (e.g., MK-6 quinones, phosphatidylethanolamine lipids, and iso-C 15:0 fatty acids), confirmed their novel status, with average amino acid identity (AAI), percentage of conserved proteins (POCP) distinguishing them from related taxa. Genomes (3.3–7.1 Mb; G + C 31.7–45.3%) revealed diverse polysaccharide utilization loci (PULs) targeting algal glycans like laminarin, alginate, and sulfated polymers (ulvan, chondroitin sulfate). Cytophagaceae 463 T harbored the richest CAZyme/PUL repertoire (131 CAZymes, 15 PULs), while Crocinitomicaceae 4-911 T lacked PULs, highlighting family-level specialization. This study expands the known diversity of core phycosphere Bacteroidota , linking PUL evolution to habitat specialization. The novel species’ distinct degradative capacities underscore their ecological roles in algal carbon processing and potential for biotechnological applications. Our integrated taxonomy-genomics approach advances understanding of microbial contributions to marine ecosystem dynamics.
- 12 May 2025
- Published by Taylor & Francis in Future Oncology
- Vol. 21 (15) , 1939-1949
Research progress on monocyte/macrophage in the development of gastric cancer
Gastric cancer (GC) is diagnosed more than one million times each year and represents a major cause of cancer-related death worldwide. Although GC presents as a group of different types of disease, chronic inflammation has been strongly associated with tumorigenesis. Monocyte/macrophage play important roles in the development of inflammation and are vital components of the tumor microenvironment (TME). Monocyte/macrophage exert protumor and/or antitumor effects through the release of angiogenic and lymphangiogenic factors. Furthermore, tumor associated macrophages (TAMs) are emerging as key players in GC development. It is necessary to review and elucidate the roles of TAM subsets in GC and their molecular features. In this study, we focused on GC-related subsets of monocytes/macrophages and analyzed signaling related to TAMs in GC as well as the potential roles of these cells as therapeutic targets.
- 12 May 2025
- Published by Taylor & Francis in Future Oncology
- Vol. 21 (15) , 1939-1949
Research progress on monocyte/macrophage in the development of gastric cancer
Gastric cancer (GC) is diagnosed more than one million times each year and represents a major cause of cancer-related death worldwide. Although GC presents as a group of different types of disease, chronic inflammation has been strongly associated with tumorigenesis. Monocyte/macrophage play important roles in the development of inflammation and are vital components of the tumor microenvironment (TME). Monocyte/macrophage exert protumor and/or antitumor effects through the release of angiogenic and lymphangiogenic factors. Furthermore, tumor associated macrophages (TAMs) are emerging as key players in GC development. It is necessary to review and elucidate the roles of TAM subsets in GC and their molecular features. In this study, we focused on GC-related subsets of monocytes/macrophages and analyzed signaling related to TAMs in GC as well as the potential roles of these cells as therapeutic targets.
- 28 January 2025
- Published by Elsevier in Progress in Biophysics and Molecular Biology
- Vol. 196, 1-7
Roles of gastric cancer-derived exosomes in the occurrence of metastatic hepatocellular carcinoma
- 28 January 2025
- Published by Elsevier in Progress in Biophysics and Molecular Biology
- Vol. 196, 1-7
Roles of gastric cancer-derived exosomes in the occurrence of metastatic hepatocellular carcinoma
- 26 July 2024
- Published by Taylor & Francis in Future Microbiology
- Vol. 19 (13) , 1145-1156
Helicobacter pylori infection delays neutrophil apoptosis and exacerbates inflammatory response
Aim: Understanding molecular mechanisms of Helicobacter pylori (H. pylori)-induced inflammation is important for developing new therapeutic strategies for gastrointestinal diseases. Materials & methods: We designed an H. pylori-neutrophil infection model and explored the effects of H. pylori infection on neutrophils. Results: H. pylori infected neutrophils showed a low level of apoptosis. H. pylori stimulation activated the NACHT/LRR/PYD domain-containing protein 3 (NLRP3)-gasdermin-D (GSDMD) pathway for interleukin (IL)-1β secretion. However, IL-1β secretion was not completely dependent on GSDMD, as inhibition of autophagy significantly reduced IL-1β release, and autophagy-related molecules were significantly upregulated in H. pylori-infected neutrophils. Conclusion: Therefore, H. pylori infection inhibits neutrophils apoptosis and induces IL-1β secretion through autophagy. These findings may be utilized to formulate therapeutic strategies against H. pylori mediated chronic gastritis.
- 26 July 2024
- Published by Taylor & Francis in Future Microbiology
- Vol. 19 (13) , 1145-1156
Helicobacter pylori infection delays neutrophil apoptosis and exacerbates inflammatory response
Aim: Understanding molecular mechanisms of Helicobacter pylori (H. pylori)-induced inflammation is important for developing new therapeutic strategies for gastrointestinal diseases. Materials & methods: We designed an H. pylori-neutrophil infection model and explored the effects of H. pylori infection on neutrophils. Results: H. pylori infected neutrophils showed a low level of apoptosis. H. pylori stimulation activated the NACHT/LRR/PYD domain-containing protein 3 (NLRP3)-gasdermin-D (GSDMD) pathway for interleukin (IL)-1β secretion. However, IL-1β secretion was not completely dependent on GSDMD, as inhibition of autophagy significantly reduced IL-1β release, and autophagy-related molecules were significantly upregulated in H. pylori-infected neutrophils. Conclusion: Therefore, H. pylori infection inhibits neutrophils apoptosis and induces IL-1β secretion through autophagy. These findings may be utilized to formulate therapeutic strategies against H. pylori mediated chronic gastritis.
- Open Access
- 18 July 2024
- Published by Springer Nature in BMC Biology
- Vol. 22 (1) , 1-13
GSRF-DTI: a framework for drug-target interaction prediction based on a drug-target pair network and representation learning on a large graph
Background: Identification of potential drug-target interactions (DTIs) with high accuracy is a key step in drug discovery and repositioning, especially concerning specific drug targets. Traditional experimental methods for identifying the DTIs are arduous, time-intensive, and financially burdensome. In addition, robust computational methods have been developed for predicting the DTIs and are widely applied in drug discovery research. However, advancing more precise algorithms for predicting DTIs is essential to meet the stringent standards demanded by drug discovery. Results: We proposed a novel method called GSRF-DTI, which integrates networks with a deep learning algorithm to identify DTIs. Firstly, GSRF-DTI learned the embedding representation of drugs and targets by integrating multiple drug association information and target association information, respectively. Then, GSRF-DTI considered the influence of drug-target pair (DTP) association on DTI prediction to construct a drug-target pair network (DTP-NET). Next, we utilized GraphSAGE on DTP-NET to learn the potential features of the network and applied random forest (RF) to predict the DTIs. Furthermore, we conducted ablation experiments to validate the necessity of integrating different types of network features for identifying DTIs. It is worth noting that GSRF-DTI proposed three novel DTIs. Conclusions: GSRF-DTI not only considered the influence of the interaction relationship between drug and target but also considered the impact of DTP association relationship on DTI prediction. We initially use GraphSAGE to aggregate the neighbor information of nodes for better identification. Experimental analysis on Luo’s dataset and the newly constructed dataset revealed that the GSRF-DTI framework outperformed several state-of-the-art methods significantly.
- 18 July 2024
- Published by Springer Nature in BMC Biology
- Vol. 22 (1) , 1-13
Open AccessGSRF-DTI: a framework for drug-target interaction prediction based on a drug-target pair network and representation learning on a large graph
Background: Identification of potential drug-target interactions (DTIs) with high accuracy is a key step in drug discovery and repositioning, especially concerning specific drug targets. Traditional experimental methods for identifying the DTIs are arduous, time-intensive, and financially burdensome. In addition, robust computational methods have been developed for predicting the DTIs and are widely applied in drug discovery research. However, advancing more precise algorithms for predicting DTIs is essential to meet the stringent standards demanded by drug discovery. Results: We proposed a novel method called GSRF-DTI, which integrates networks with a deep learning algorithm to identify DTIs. Firstly, GSRF-DTI learned the embedding representation of drugs and targets by integrating multiple drug association information and target association information, respectively. Then, GSRF-DTI considered the influence of drug-target pair (DTP) association on DTI prediction to construct a drug-target pair network (DTP-NET). Next, we utilized GraphSAGE on DTP-NET to learn the potential features of the network and applied random forest (RF) to predict the DTIs. Furthermore, we conducted ablation experiments to validate the necessity of integrating different types of network features for identifying DTIs. It is worth noting that GSRF-DTI proposed three novel DTIs. Conclusions: GSRF-DTI not only considered the influence of the interaction relationship between drug and target but also considered the impact of DTP association relationship on DTI prediction. We initially use GraphSAGE to aggregate the neighbor information of nodes for better identification. Experimental analysis on Luo’s dataset and the newly constructed dataset revealed that the GSRF-DTI framework outperformed several state-of-the-art methods significantly.
- Open Access
- 29 April 2024
- Published by Public Library of Science (PLoS) in PLOS Computational Biology
- Vol. 20 (4) , e1012068
A novel hypergraph model for identifying and prioritizing personalized drivers in cancer
Cancer development is driven by an accumulation of a small number of driver genetic mutations that confer the selective growth advantage to the cell, while most passenger mutations do not contribute to tumor progression. The identification of these driver genes responsible for tumorigenesis is a crucial step in designing effective cancer treatments. Although many computational methods have been developed with this purpose, the majority of existing methods solely provided a single driver gene list for the entire cohort of patients, ignoring the high heterogeneity of driver events across patients. It remains challenging to identify the personalized driver genes. Here, we propose a novel method (PDRWH), which aims to prioritize the mutated genes of a single patient based on their impact on the abnormal expression of downstream genes across a group of patients who share the co-mutation genes and similar gene expression profiles. The wide experimental results on 16 cancer datasets from TCGA showed that PDRWH excels in identifying known general driver genes and tumor-specific drivers. In the comparative testing across five cancer types, PDRWH outperformed existing individual-level methods as well as cohort-level methods. Our results also demonstrated that PDRWH could identify both common and rare drivers. The personalized driver profiles could improve tumor stratification, providing new insights into understanding tumor heterogeneity and taking a further step toward personalized treatment. We also validated one of our predicted novel personalized driver genes on tumor cell proliferation by vitro cell-based assays, the promoting effect of the high expression of Low-density lipoprotein receptor-related protein 1 (LRP1) on tumor cell proliferation.
- 29 April 2024
- Published by Public Library of Science (PLoS) in PLOS Computational Biology
- Vol. 20 (4) , e1012068
Open AccessA novel hypergraph model for identifying and prioritizing personalized drivers in cancer
Cancer development is driven by an accumulation of a small number of driver genetic mutations that confer the selective growth advantage to the cell, while most passenger mutations do not contribute to tumor progression. The identification of these driver genes responsible for tumorigenesis is a crucial step in designing effective cancer treatments. Although many computational methods have been developed with this purpose, the majority of existing methods solely provided a single driver gene list for the entire cohort of patients, ignoring the high heterogeneity of driver events across patients. It remains challenging to identify the personalized driver genes. Here, we propose a novel method (PDRWH), which aims to prioritize the mutated genes of a single patient based on their impact on the abnormal expression of downstream genes across a group of patients who share the co-mutation genes and similar gene expression profiles. The wide experimental results on 16 cancer datasets from TCGA showed that PDRWH excels in identifying known general driver genes and tumor-specific drivers. In the comparative testing across five cancer types, PDRWH outperformed existing individual-level methods as well as cohort-level methods. Our results also demonstrated that PDRWH could identify both common and rare drivers. The personalized driver profiles could improve tumor stratification, providing new insights into understanding tumor heterogeneity and taking a further step toward personalized treatment. We also validated one of our predicted novel personalized driver genes on tumor cell proliferation by vitro cell-based assays, the promoting effect of the high expression of Low-density lipoprotein receptor-related protein 1 (LRP1) on tumor cell proliferation.
- Open Access
- 1 December 2023
- Published by Oxford University Press (OUP) in Bioinformatics
- Vol. 39 (12)
MaxCLK: discovery of cancer driver genes via maximal clique and information entropy of modules
Motivation: Cancer is caused by the accumulation of somatic mutations in multiple pathways, in which driver mutations are typically of the properties of high coverage and high exclusivity in patients. Identifying cancer driver genes has a pivotal role in understanding the mechanisms of oncogenesis and treatment. Results: Here, we introduced MaxCLK, an algorithm for identifying cancer driver genes, which was developed by an integrated analysis of somatic mutation data and protein–protein interaction (PPI) networks and further improved by an information entropy index. Tested on pancancer and single cancers, MaxCLK outperformed other existing methods with higher accuracy. About pancancer, we predicted 154 driver genes and 787 driver modules. The analysis of co-occurrence and exclusivity between modules and pathways reveals the correlation of their combinations. Overall, our study has deepened the understanding of driver mechanism in PPI topology and found novel driver genes. Availability and implementation: The source codes for MaxCLK are freely available at https://github.com/ShandongUniversityMasterMa/MaxCLK-main.
- 1 December 2023
- Published by Oxford University Press (OUP) in Bioinformatics
- Vol. 39 (12)
Open AccessMaxCLK: discovery of cancer driver genes via maximal clique and information entropy of modules
Motivation: Cancer is caused by the accumulation of somatic mutations in multiple pathways, in which driver mutations are typically of the properties of high coverage and high exclusivity in patients. Identifying cancer driver genes has a pivotal role in understanding the mechanisms of oncogenesis and treatment. Results: Here, we introduced MaxCLK, an algorithm for identifying cancer driver genes, which was developed by an integrated analysis of somatic mutation data and protein–protein interaction (PPI) networks and further improved by an information entropy index. Tested on pancancer and single cancers, MaxCLK outperformed other existing methods with higher accuracy. About pancancer, we predicted 154 driver genes and 787 driver modules. The analysis of co-occurrence and exclusivity between modules and pathways reveals the correlation of their combinations. Overall, our study has deepened the understanding of driver mechanism in PPI topology and found novel driver genes. Availability and implementation: The source codes for MaxCLK are freely available at https://github.com/ShandongUniversityMasterMa/MaxCLK-main.
- Open Access
- 2 November 2023
- Published by Microbiology Society in International Journal of Systematic and Evolutionary Microbiology
- Vol. 73 (11) , 006130
Marinicella marina sp. nov. and Marinicella gelatinilytica sp. nov., isolated from coastal sediment, and genome analysis and habitat distribution of the genus Marinicella
Three Marinicella strains, X102, S1101T and S6413T, were isolated from sediment samples from different coasts of Weihai, PR China. All strains were Gram-stain-negative, rod-shaped and non-motile. The predominant fatty acids of all strains were iso-C15 : 0 and summed feature 3 (C16 : 1 ω7c/C16 : 1 ω6c) and the major polar lipids comprised phosphatidylethanolamine, phosphatidylglycerol and diphosphatidylglycerol. Strains X102 and S1101T shared 100 % 16S rRNA gene sequence similarity, and strains S1101T/X102 and S6413T had 95.4 % similarity. The average nucleotide identity (ANI) and digital DNA–DNA hybridization (dDDH) values between strains S1101T and X102 were 99.9 and 99.2 %, respectively. Strain S1101T had ANI values of 69.1–72.9% and dDDH values of 17.9–20.5 % to members of the genus Marinicella . Strain S6413T had ANI values of 69.1–77.5% and dDDH values of 17.6–21.5 % to members of the genus Marinicella . The results of phylogenetic and comparative genomic analysis showed that the three strains belong to two novel species in the genus Marinicella , and strains X102 and S1101T represented one novel species, and strain S6413T represented another novel species. The result of BOX-PCR and genomic analysis showed that X102 and S1101T were not the same strain. The phylogenetic analyses and genomic comparisons, combined with phylogenetic, phenotypic and chemotaxonomic features, strongly supported that the three strains should be classified as representing two novel species of the genus Marinicella , for which the names Marinicella marina sp. nov. and Marinicella gelatinilytica sp. nov. are proposed, respectively. The type strains of the two novel species are S1101T (=KCTC 92642T=MCCC 1H01359T) and S6413T (=KCTC 92641T=MCCC 1H01362T), respectively. In addition, all previously described isolates of Marinicella were isolated from marine environments, but our study showed that Marinicella is also distributed in non-/low-saline habitats (e.g. animal gut, soil and indoor surface), which broadened our perception of the environmental distribution of Marinicella .
- 2 November 2023
- Published by Microbiology Society in International Journal of Systematic and Evolutionary Microbiology
- Vol. 73 (11) , 006130
Open AccessMarinicella marina sp. nov. and Marinicella gelatinilytica sp. nov., isolated from coastal sediment, and genome analysis and habitat distribution of the genus Marinicella
Three Marinicella strains, X102, S1101T and S6413T, were isolated from sediment samples from different coasts of Weihai, PR China. All strains were Gram-stain-negative, rod-shaped and non-motile. The predominant fatty acids of all strains were iso-C15 : 0 and summed feature 3 (C16 : 1 ω7c/C16 : 1 ω6c) and the major polar lipids comprised phosphatidylethanolamine, phosphatidylglycerol and diphosphatidylglycerol. Strains X102 and S1101T shared 100 % 16S rRNA gene sequence similarity, and strains S1101T/X102 and S6413T had 95.4 % similarity. The average nucleotide identity (ANI) and digital DNA–DNA hybridization (dDDH) values between strains S1101T and X102 were 99.9 and 99.2 %, respectively. Strain S1101T had ANI values of 69.1–72.9% and dDDH values of 17.9–20.5 % to members of the genus Marinicella . Strain S6413T had ANI values of 69.1–77.5% and dDDH values of 17.6–21.5 % to members of the genus Marinicella . The results of phylogenetic and comparative genomic analysis showed that the three strains belong to two novel species in the genus Marinicella , and strains X102 and S1101T represented one novel species, and strain S6413T represented another novel species. The result of BOX-PCR and genomic analysis showed that X102 and S1101T were not the same strain. The phylogenetic analyses and genomic comparisons, combined with phylogenetic, phenotypic and chemotaxonomic features, strongly supported that the three strains should be classified as representing two novel species of the genus Marinicella , for which the names Marinicella marina sp. nov. and Marinicella gelatinilytica sp. nov. are proposed, respectively. The type strains of the two novel species are S1101T (=KCTC 92642T=MCCC 1H01359T) and S6413T (=KCTC 92641T=MCCC 1H01362T), respectively. In addition, all previously described isolates of Marinicella were isolated from marine environments, but our study showed that Marinicella is also distributed in non-/low-saline habitats (e.g. animal gut, soil and indoor surface), which broadened our perception of the environmental distribution of Marinicella .